Skip to main content

$0.021 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
26 June 2025 at 2:03pm
Register to track HXL and receive email alerts.
Subject
HXL Ann: Proposed issue of securities - HXL

HXL Ann: Completion of $10 Million Institutional Placement

HXL Ann: Trading Halt

HXL Ann: Quarterly Activities Report and Appendix 4C

HXL Ann: AusBiotech Invest Presentation

HXL Ann: Presenting at AusBiotech

HXL Ann: Appointment of Company Secretary

HXL Ann: Application for quotation of securities - HXL

HXL Ann: Presenting at Switzer Small & Micro-Cap Virtual Investor Day

HXL Ann: ACCESS CHINA Biotech Forum

HXL Ann: Restricted Securities to be Released from Escrow

HXL Ann: Notification regarding unquoted securities - HXL

HXL Ann: ASX Small and Mid-Cap Conference Presentation

HXL Ann: Review of FY21 - Investor Webinar

HXL Ann: Corporate Governance Statement

HXL Ann: Review of FY21 - Investor Webinar

HXL Ann: Investor Webinar on Today

HXL Ann: Appendix 3X

HXL Ann: Appointment of Jake Nunn as Non-Executive Director

HXL Ann: Annual Report 2021

HXL Ann: Appendix 4E

HXL Ann: Appendix 4G

HXL Ann: China Patent for Pezadeftide Granted

HXL Ann: Design Patent for Pezadeftide Commercial Packaging

HXL Ann: APMA presentation and investor webinar

HXL Ann: Quarterly Activities Report and Appendix 4C

HXL Ann: Completion of enrolment in Phase IIb Clinical Trial

HXL Ann: Presenting Clinical Data at APMA and Investor Webinar

HXL Ann: Grant of European Patent over Pezadeftide

HXL Ann: Media Interview and Investor Presentation

HXL Ann: ShareCafe Presentation

HXL Ann: Hexima receives INN designation for HXP124

HXL Ann: Grant of HXP124 Patent

HXL Ann: Quarterly Activities Report and Appendix 4C

HXL Ann: Hexima to Present at APMA

HXL Ann: R&D Webinar on Today

HXL Ann: SAB Formation and R&D Video Conference

HXL Ann: Half Year Report and Accounts

HXL Ann: Statement pursuant to ASX listing rule 4.7C.2

HXL Ann: Transcript of Investor 4th Quarter Call

HXL Ann: Quarterly Activity Report

HXL Ann: Appendix 4C Cash Flow Report

HXL Ann: Quarterly Report & Investor Conference Call Updated

HXL Ann: Notification of Quarterly Report & Investor Conference Call

HXL Ann: Updated timeline to Phase 2B results

HXL Ann: Hexima Quarter 3 Newsletter, Nail Mail

HXL Ann: Hexima Presentation

HXL Ann: Public Offer and Listing Announcement, Hexima Limited

HXL Ann: Becoming a substantial holder from GOW

HXL Ann: Becoming a substantial holder

Register to track HXL and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX